Ultimovacs ultimovacs.com


Public list: BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180)

Ultimovacs was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to make the treatment available to patients. The technology is based on the possibility of controlling the immune system to make it recognize and kill cancer cells. Ultimovacs is carrying out three clinical trials intended to document that the company's main product, UV1, can produce a controlled immune response and is safe to use, either al...Show all

Ultimovacs was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to make the treatment available to patients. The technology is based on the possibility of co...Show all

Company (Alive / Active)

Phone: + 47 909 71 226

Fax:

Gaustadalléen 21

0349
Norway

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ultimovacs $5.9M Jan 22, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ultimovacs Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Telomerase polypeptide vaccine for treating cancer Feb 15, 2011 May 23, 2017 Patent
Telomerase polypeptide vaccine for treating cancer Apr 27, 2017 Application
Telomerase polypeptide vaccine for treating cancer Apr 27, 2017 Application